Ambrosia Biosciences
Boulder
About Ambrosia Biosciences
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $141.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2026)
- Website: ambrosiabiosciences.com
- Phone: +1 303 351-5800
Industries & Categories
Biopharma, Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/ambrosia-biosciences-80839 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.